ipharmaservices2 days agoMay witnessed the approval of Pfizer’s Talzenna, Nyprax’s Tukysa, Drug Houses’ Ajovy in Singapore
ipharmaservices3 days agoGilead announced the positive Phase 3 trial of remdesivir in COVID-19 patients